BCL2L13

Bcl-2-like protein 13 · Q9BXK5 · BCL2L13 on Sugi Atlas →

0 patent compounds predicted against BCL2L13, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to BCL2L13 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer PHASE4UNKNOWN
Daunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid Leukemia PHASE3COMPLETED
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia PHASE3COMPLETED
Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients PHASE3ACTIVE_NOT_RECRUITING
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma PHASE2RECRUITING
Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme PHASE2COMPLETED
Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors PHASE1/PHASE2COMPLETED
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL PHASE1/PHASE2ACTIVE_NOT_RECRUITING
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in Combination With Bortezomib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL) PHASE1/PHASE2COMPLETED
Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL PHASE2RECRUITING
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia PHASE2ACTIVE_NOT_RECRUITING
Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission PHASE2ACTIVE_NOT_RECRUITING
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant PHASE1/PHASE2RECRUITING
A Study of CPI-613 for Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-Grade B-Cell Lymphoma With High-Risk Translocations PHASE2ACTIVE_NOT_RECRUITING
TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma PHASE1/PHASE2RECRUITING
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme PHASE1COMPLETED
Bcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node Metastases PHASE1COMPLETED
Safe Accelerated Venetoclax Escalation in CLL PHASE1ACTIVE_NOT_RECRUITING
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN PHASE1ACTIVE_NOT_RECRUITING
Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19 and/or BCMA PHASE1RECRUITING
Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan nanUNKNOWN
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings nanACTIVE_NOT_RECRUITING
The Effect of TRA-8 on Ovarian Cancer Tissue nanCOMPLETED
Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient nanNOT_YET_RECRUITING
Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA. nanRECRUITING
Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia nanCOMPLETED
Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer nanCOMPLETED
Dietary Intervention With High Phenolic EVOO in CLL nanCOMPLETED
Smoking Influence on Apoptosis in Periodontitis nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a BCL2L13 binder may also engage these)

ProteinNameSimilarity
P59017 1.000 P59017 →
Q501R9 0.988 Q501R9 →
P97432 0.987 P97432 →
Q9QXM1 0.985 Q9QXM1 →
Q14596 0.985 Q14596 →
Q8N9B5 0.984 Q8N9B5 →
A8E4X8 0.984 A8E4X8 →
Q3MHU5 0.982 Q3MHU5 →
Q92543 0.981 Q92543 →
O75129 0.981 O75129 →
Q812A5 0.981 Q812A5 →
Q8AVJ1 0.981 Q8AVJ1 →
Q6NS82 0.981 Q6NS82 →
Q5FVM3 0.981 Q5FVM3 →
B0BMZ6 0.981 B0BMZ6 →
Q8VE91 0.980 Q8VE91 →
Q9UHY8 0.980 Q9UHY8 →
P97817 0.980 P97817 →
Q8K3I4 0.980 Q8K3I4 →
Q7Z5B4 0.980 Q7Z5B4 →
P49140 0.979 P49140 →
Q96EV8 0.979 Q96EV8 →
Q6NZQ0 0.979 Q6NZQ0 →
Q9BZQ8 0.979 Q9BZQ8 →
Q8K2L8 0.979 Q8K2L8 →
Q8NC44 0.979 Q8NC44 →
Q5XI52 0.979 Q5XI52 →
Q3B7M3 0.979 Q3B7M3 →
Q5E9K8 0.979 Q5E9K8 →
Q9H204 0.978 Q9H204 →